Significance of indeterminate reactivity to human T-Cell lymphotropic virus in Western blot analysis of individuals at risk

被引:11
作者
Medrano, FJ
Soriano, V
Calderon, EJ
Rey, C
Gutierrez, M
Bravo, R
Leal, M
GonzalezLahoz, J
Lissen, E
机构
[1] VIRGEN DEL ROCIO UNIV HOSP,DEPT INTERNAL MED,SEVILLE 41013,SPAIN
[2] VIRGEN DEL ROCIO UNIV HOSP,DEPT BIOCHEM,VIRAL HEPATITIS & AIDS STUDY GRP,SEVILLE 41013,SPAIN
[3] INST SALUD CARLOS III,CTR INVEST CLIN,INFECT DIS SERV,MADRID,SPAIN
[4] INST SALUD CARLOS III,CTR INVEST CLIN,MICROBIOL SERV,MADRID,SPAIN
关键词
D O I
10.1007/BF01709592
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Current tests to confirm human T-cell lymphotropic virus (HTLV) infection in individuals at risk of retroviral infection commonly yield indeterminate results. To assess the significance of HTLV-seroindeterminate reactivities in a high-risk population, 16 at-risk individuals who had this serologic pattern by Western blot were studied using a polymerase chain reaction (PCR) assay. Human T-cell lymphotropic virus type II infection was confirmed by the presence of virus-specific nucleic acid in four patients. However, PCR analysis was negative in the remaining 12 individuals. These results indicate strongly that all specimens from at-risk individuals with nondiagnostic HTLV reactivity by current Western blot assay should continue to be considered inconclusive, requiring further testing by more sensitive tests.
引用
收藏
页码:249 / 252
页数:4
相关论文
共 15 条
[1]  
BIGGAR RJ, 1987, NEW ENGL J MED, V316, P630, DOI 10.1056/NEJM198703053161015
[2]   IMMUNE RESPONSIVENESS TO THE IMMUNODOMINANT RECOMBINANT ENVELOPE EPITOPES OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 AND TYPE-2 IN DIVERSE GEOGRAPHIC POPULATIONS [J].
BUCKNER, C ;
ROBERTS, CR ;
FOUNG, SKH ;
LIPKA, J ;
REYES, GR ;
HADLOCK, K ;
CHAN, L ;
GONGORABIACHI, A ;
HJELLE, B ;
LAL, RB .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) :1160-1163
[3]  
BUSCH MP, 1994, BLOOD, V83, P1143
[4]  
CALDERON E, 1995, ALPE ADRIA MICROBIOL, V2, P86
[5]   PREVALENCE OF INFECTION BY HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I AND TYPE-II IN SOUTHERN SPAIN [J].
CALDERON, EJ ;
REY, C ;
MEDRANO, FJ ;
SANCHEZROMAN, J ;
SORIANO, V ;
TORRES, Y ;
RUIZ, M ;
LISSEN, E ;
LEAL, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) :686-690
[6]  
*CDCP, 1993, ANN INTERN MED, V118, P448
[7]   LOSS OF ANTIBODIES AGAINST HEPATITIS-C VIRUS IN HIV-SEROPOSITIVE INTRAVENOUS-DRUG-USERS [J].
CHAMOT, E ;
HIRSCHEL, B ;
WINTSCH, J ;
ROBERT, CF ;
GABRIEL, V ;
DEGLON, JJ ;
YERLY, S ;
PERRIN, L .
AIDS, 1990, 4 (12) :1275-1277
[8]  
EHRLICH GD, 1989, BLOOD, V74, P1658
[9]   PREVALENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 (HTLV-1) AND HTLV-2 INFECTION AMONG SPANISH DRUG-USERS MEASURED BY HTLV-1 ASSAY AND HTLV-1 AND HTLV-2 ASSAY [J].
HENRARD, DR ;
SORIANO, V ;
ROBERTSON, E ;
GUTIERREZ, M ;
STEPHENS, J ;
DRONDA, F ;
MILES, F ;
PUJOL, E ;
BUYTENDORP, M ;
CASTRO, A ;
CHAN, E ;
VALLEJO, A ;
LLIBRE, J ;
MOTLEY, C ;
PRILLAMAN, J ;
CALDERON, E ;
LEAL, M ;
TUSET, C ;
MARTINEZZAPICO, R ;
CABALLERO, E ;
ORTIZ, R ;
EIROS, J ;
AGUILERA, A ;
ULLOA, F ;
MARTIN, AM ;
RODRIGUEZIGLESIAS, A ;
RIVERA, A ;
BOUZA, E ;
ESPARZA, B ;
MERINO, F ;
TOR, J ;
ESCUDERO, D ;
RIBERA, J ;
DELROMERO, J ;
RODRIGUEZ, C ;
PEDREIRA, J ;
HEREDIA, A ;
HEWLETT, I ;
GONZALEZLAHOZ, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (07) :1735-1738
[10]   HUMAN LYMPHOTROPIC-T VIRUS TYPE-II (HTLV-II) INFECTION IN A COHORT OF NEW-YORK INTRAVENOUS-DRUG-USERS - AN OLD INFECTION [J].
KHABBAZ, RF ;
HARTEL, D ;
LAIRMORE, M ;
HORSBURGH, CR ;
SCHOENBAUM, EE ;
ROBERTS, B ;
HARTLEY, TM ;
FRIEDLAND, G .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :252-256